The Experts below are selected from a list of 1224 Experts worldwide ranked by ideXlab platform

Jose López-lópez - One of the best experts on this subject based on the ideXlab platform.

  • Review Article Pyogenic Granuloma/Peripheral Giant-Cell Granuloma Associated with Implants
    2016
    Co-Authors: Enric Jané-salas, Rui Albuquerque, Aura Font-muñoz, Beatríz González-navarro, Albert Estrugo Devesa, Jose López-lópez
    Abstract:

    Copyright © 2015 Enric Jané-Salas et al.This is an open access article distributed under theCreative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. Pyogenic Granuloma (PG) and Peripheral Giant-Cell Granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed.Methods. To collect relevant information about previous treatments for PG and PGCG involving implants w

  • Pyogenic Granuloma/Peripheral Giant-Cell Granuloma Associated with Implants
    International journal of dentistry, 2015
    Co-Authors: Enric Jané-salas, Rui Albuquerque, Aura Font-muñoz, Beatríz González-navarro, Albert Estrugo Devesa, Jose López-lópez
    Abstract:

    Introduction. Pyogenic Granuloma (PG) and Peripheral Giant-Cell Granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed. Methods. To collect relevant information about previous treatments for PG and PGCG involving implants we carried out electronic searches of publications with the key words "Granuloma", "oral", and "implants" from the last 15 years on the databases Pubmed, National Library of Medicine's Medline, Scielo, Scopus, and Cochrane Library. Results. From the electronic search 16 case reports were found showing excision and curettage as the main successful treatment. As no clinical trials or observational studies were identified the authors agreed to present results from a review perspective. Conclusion. This is the largest analysis of PG and PGCG associated with implants published to date. Our review would suggest that PGCG associated with implants appears to have a more aggressive nature; however the level of evidence is very limited. Further cohort studies with representative sample sizes and standard outcome measures are necessary for better understanding of these conditions.

Albert Estrugo Devesa - One of the best experts on this subject based on the ideXlab platform.

  • Review Article Pyogenic Granuloma/Peripheral Giant-Cell Granuloma Associated with Implants
    2016
    Co-Authors: Enric Jané-salas, Rui Albuquerque, Aura Font-muñoz, Beatríz González-navarro, Albert Estrugo Devesa, Jose López-lópez
    Abstract:

    Copyright © 2015 Enric Jané-Salas et al.This is an open access article distributed under theCreative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. Pyogenic Granuloma (PG) and Peripheral Giant-Cell Granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed.Methods. To collect relevant information about previous treatments for PG and PGCG involving implants w

  • pyogenic Granuloma Peripheral giant cell Granuloma associated with implants
    International Journal of Dentistry, 2015
    Co-Authors: Enric Janesalas, Rui Albuquerque, Albert Estrugo Devesa, Aura Fontmunoz, Beatriz Gonzaleznavarro, Jose Lopezlopez
    Abstract:

    Introduction. Pyogenic Granuloma (PG) and Peripheral Giant-Cell Granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed. Methods. To collect relevant information about previous treatments for PG and PGCG involving implants we carried out electronic searches of publications with the key words "Granuloma", "oral", and "implants" from the last 15 years on the databases Pubmed, National Library of Medicine's Medline, Scielo, Scopus, and Cochrane Library. Results. From the electronic search 16 case reports were found showing excision and curettage as the main successful treatment. As no clinical trials or observational studies were identified the authors agreed to present results from a review perspective. Conclusion. This is the largest analysis of PG and PGCG associated with implants published to date. Our review would suggest that PGCG associated with implants appears to have a more aggressive nature; however the level of evidence is very limited. Further cohort studies with representative sample sizes and standard outcome measures are necessary for better understanding of these conditions.

  • Pyogenic Granuloma/Peripheral Giant-Cell Granuloma Associated with Implants
    International journal of dentistry, 2015
    Co-Authors: Enric Jané-salas, Rui Albuquerque, Aura Font-muñoz, Beatríz González-navarro, Albert Estrugo Devesa, Jose López-lópez
    Abstract:

    Introduction. Pyogenic Granuloma (PG) and Peripheral Giant-Cell Granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed. Methods. To collect relevant information about previous treatments for PG and PGCG involving implants we carried out electronic searches of publications with the key words "Granuloma", "oral", and "implants" from the last 15 years on the databases Pubmed, National Library of Medicine's Medline, Scielo, Scopus, and Cochrane Library. Results. From the electronic search 16 case reports were found showing excision and curettage as the main successful treatment. As no clinical trials or observational studies were identified the authors agreed to present results from a review perspective. Conclusion. This is the largest analysis of PG and PGCG associated with implants published to date. Our review would suggest that PGCG associated with implants appears to have a more aggressive nature; however the level of evidence is very limited. Further cohort studies with representative sample sizes and standard outcome measures are necessary for better understanding of these conditions.

Rui Albuquerque - One of the best experts on this subject based on the ideXlab platform.

  • Review Article Pyogenic Granuloma/Peripheral Giant-Cell Granuloma Associated with Implants
    2016
    Co-Authors: Enric Jané-salas, Rui Albuquerque, Aura Font-muñoz, Beatríz González-navarro, Albert Estrugo Devesa, Jose López-lópez
    Abstract:

    Copyright © 2015 Enric Jané-Salas et al.This is an open access article distributed under theCreative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. Pyogenic Granuloma (PG) and Peripheral Giant-Cell Granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed.Methods. To collect relevant information about previous treatments for PG and PGCG involving implants w

  • pyogenic Granuloma Peripheral giant cell Granuloma associated with implants
    International Journal of Dentistry, 2015
    Co-Authors: Enric Janesalas, Rui Albuquerque, Albert Estrugo Devesa, Aura Fontmunoz, Beatriz Gonzaleznavarro, Jose Lopezlopez
    Abstract:

    Introduction. Pyogenic Granuloma (PG) and Peripheral Giant-Cell Granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed. Methods. To collect relevant information about previous treatments for PG and PGCG involving implants we carried out electronic searches of publications with the key words "Granuloma", "oral", and "implants" from the last 15 years on the databases Pubmed, National Library of Medicine's Medline, Scielo, Scopus, and Cochrane Library. Results. From the electronic search 16 case reports were found showing excision and curettage as the main successful treatment. As no clinical trials or observational studies were identified the authors agreed to present results from a review perspective. Conclusion. This is the largest analysis of PG and PGCG associated with implants published to date. Our review would suggest that PGCG associated with implants appears to have a more aggressive nature; however the level of evidence is very limited. Further cohort studies with representative sample sizes and standard outcome measures are necessary for better understanding of these conditions.

  • Pyogenic Granuloma/Peripheral Giant-Cell Granuloma Associated with Implants
    International journal of dentistry, 2015
    Co-Authors: Enric Jané-salas, Rui Albuquerque, Aura Font-muñoz, Beatríz González-navarro, Albert Estrugo Devesa, Jose López-lópez
    Abstract:

    Introduction. Pyogenic Granuloma (PG) and Peripheral Giant-Cell Granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed. Methods. To collect relevant information about previous treatments for PG and PGCG involving implants we carried out electronic searches of publications with the key words "Granuloma", "oral", and "implants" from the last 15 years on the databases Pubmed, National Library of Medicine's Medline, Scielo, Scopus, and Cochrane Library. Results. From the electronic search 16 case reports were found showing excision and curettage as the main successful treatment. As no clinical trials or observational studies were identified the authors agreed to present results from a review perspective. Conclusion. This is the largest analysis of PG and PGCG associated with implants published to date. Our review would suggest that PGCG associated with implants appears to have a more aggressive nature; however the level of evidence is very limited. Further cohort studies with representative sample sizes and standard outcome measures are necessary for better understanding of these conditions.

Jose Lopezlopez - One of the best experts on this subject based on the ideXlab platform.

  • pyogenic Granuloma Peripheral giant cell Granuloma associated with implants
    International Journal of Dentistry, 2015
    Co-Authors: Enric Janesalas, Rui Albuquerque, Albert Estrugo Devesa, Aura Fontmunoz, Beatriz Gonzaleznavarro, Jose Lopezlopez
    Abstract:

    Introduction. Pyogenic Granuloma (PG) and Peripheral Giant-Cell Granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed. Methods. To collect relevant information about previous treatments for PG and PGCG involving implants we carried out electronic searches of publications with the key words "Granuloma", "oral", and "implants" from the last 15 years on the databases Pubmed, National Library of Medicine's Medline, Scielo, Scopus, and Cochrane Library. Results. From the electronic search 16 case reports were found showing excision and curettage as the main successful treatment. As no clinical trials or observational studies were identified the authors agreed to present results from a review perspective. Conclusion. This is the largest analysis of PG and PGCG associated with implants published to date. Our review would suggest that PGCG associated with implants appears to have a more aggressive nature; however the level of evidence is very limited. Further cohort studies with representative sample sizes and standard outcome measures are necessary for better understanding of these conditions.

Enric Jané-salas - One of the best experts on this subject based on the ideXlab platform.

  • Review Article Pyogenic Granuloma/Peripheral Giant-Cell Granuloma Associated with Implants
    2016
    Co-Authors: Enric Jané-salas, Rui Albuquerque, Aura Font-muñoz, Beatríz González-navarro, Albert Estrugo Devesa, Jose López-lópez
    Abstract:

    Copyright © 2015 Enric Jané-Salas et al.This is an open access article distributed under theCreative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. Pyogenic Granuloma (PG) and Peripheral Giant-Cell Granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed.Methods. To collect relevant information about previous treatments for PG and PGCG involving implants w

  • Pyogenic Granuloma/Peripheral Giant-Cell Granuloma Associated with Implants
    International journal of dentistry, 2015
    Co-Authors: Enric Jané-salas, Rui Albuquerque, Aura Font-muñoz, Beatríz González-navarro, Albert Estrugo Devesa, Jose López-lópez
    Abstract:

    Introduction. Pyogenic Granuloma (PG) and Peripheral Giant-Cell Granuloma (PGCG) are two of the most common inflammatory lesions associated with implants; however, there is no established pathway for treatment of these conditions. This paper aims to illustrate the successful treatment of PG and PGCG and also report a systematic review of the literature regarding the various treatments proposed. Methods. To collect relevant information about previous treatments for PG and PGCG involving implants we carried out electronic searches of publications with the key words "Granuloma", "oral", and "implants" from the last 15 years on the databases Pubmed, National Library of Medicine's Medline, Scielo, Scopus, and Cochrane Library. Results. From the electronic search 16 case reports were found showing excision and curettage as the main successful treatment. As no clinical trials or observational studies were identified the authors agreed to present results from a review perspective. Conclusion. This is the largest analysis of PG and PGCG associated with implants published to date. Our review would suggest that PGCG associated with implants appears to have a more aggressive nature; however the level of evidence is very limited. Further cohort studies with representative sample sizes and standard outcome measures are necessary for better understanding of these conditions.